Your browser doesn't support javascript.
COVID-19 SARS-CoV-2 Antibody Testing Study
ClinicalTrials.gov; 12/08/2021; TrialID: NCT05009888
Clinical Trial Register | ICTRP | ID: ictrp-NCT05009888
ABSTRACT

Condition

Healthy

Primary 

outcome:

Acceptability of performing antibody testing procedures involving a capillary blood sample collected via finger-prick;Test validity of the antibody tests that are performed

Criteria


Inclusion Criteria

- King's College Staff member

- Aged 18 years or over

- Able to freely give informed consent

Exclusion Criteria

The participant may not enter the study if ANY of the following apply

- known to have an infectious disease including a current SARS-CoV-2 infection.

- Any significant disease or disorder which, in the opinion of the Investigator, may
either put the participants at risk because of participation in the research study, or
may influence the result of the research study, or the participant's ability to
participate in the research study. Examples of disorders or diseases which would be
excluded include

- Medically diagnosed bleeding disorder;

- Medically diagnosed platelet disorder;

- Anticoagulant medication.


Collection: Clinical trial registers Database: ICTRP Year: 2021 Document Type: Clinical Trial Register

Similar

MEDLINE

...
LILACS

LIS

Collection: Clinical trial registers Database: ICTRP Year: 2021 Document Type: Clinical Trial Register